Does NIFEDIPINE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with NIFEDIPINE (Nifedipine). This represents 0.1% of all adverse event reports for NIFEDIPINE.
6
Reports of Malignant neoplasm progression with NIFEDIPINE
0.1%
of all NIFEDIPINE reports
2
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From NIFEDIPINE?
Of the 6 reports, 2 (33.3%) resulted in death, 1 (16.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIFEDIPINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does NIFEDIPINE Cause?
Foetal exposure during pregnancy (927)
Drug ineffective (883)
Premature baby (791)
Maternal exposure during pregnancy (704)
Premature delivery (555)
Exposure during pregnancy (524)
Hypotension (505)
Off label use (474)
Drug hypersensitivity (459)
Completed suicide (431)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which NIFEDIPINE Alternatives Have Lower Malignant neoplasm progression Risk?
NIFEDIPINE vs NILOTINIB
NIFEDIPINE vs NIMESULIDE
NIFEDIPINE vs NIMODIPINE
NIFEDIPINE vs NINTEDANIB
NIFEDIPINE vs NINTEDANIB ESYLATE